Join the Wegovy group to help and get support from people like you.
Wegovy News (Page 7)
Should Kids Take Ozempic, Wegovy? The Idea Has Some Experts Worried
WEDNESDAY, Aug. 30, 2023 – Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone. Glucagon-like peptide-1 receptor agonists (GLP-1RA) ma...
ESC: Semaglutide Beneficial for HFpEF Patients With Obesity
TUESDAY, Aug. 29, 2023 – For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations,...
Wegovy May Be Valuable New Option for Heart Failure Patients
FRIDAY, Aug. 25, 2023 – Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs...
FDA Medwatch Alert: FDA Issues Warning About Compounded Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
On May 30, 2023, the FDA posted information about medications containing semaglutide marketed for type 2 diabetes or weight loss. There are currently three FDA-approved semaglutide products which are...
FDA Approves Once-Weekly Wegovy injection for the Treatment of Obesity in Teens Aged 12 Years and Older
New indication based on clinical trial that demonstrated a 16.1% reduction in body mass index (BMI) in teens with obesity treated with Wegovy® (semaglutide) injection 2.4 mg compared to placebo ...
FDA Approves Wegovy (semaglutide) to Treat Adults with Obesity
PLAINSBORO, N.J., June 4, 2021 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injec...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction